Brief: Guard Therapeutics Explores Strategic Alternatives

Disruptive Pharma AB (publ)

05/12/2025 08:32

Dec 5 (Reuters) - Guard Therapeutics AB GUARD.ST:

SAID ON THURSDAY BOARD OF DIRECTORS HAS RESOLVED TO COMMENCE AN EXPLORATORY PROCESS REGARDING STRATEGIC ALTERNATIVES

PROCESS INCLUDES TO IDENTIFY A GROWTH COMPANY WITH AMBITION FOR LISTING OR NEED FOR ADDITIONAL CAPITAL, WHERE A MERGER OR REVERSE ACQUISITION COULD REPRESENT A PATH FORWARD

IF NO STRATEGIC ALTERNATIVES MATERIALIZE WITHIN A REASONABLE TIMEFRAME, BOARD TO RECOMMEND DELISTING FROM NASDAQ FIRST NORTH GROWTH MARKET AND VOLUNTARY LIQUIDATION

CO ASSESSES THAT ITS CURRENT CASH POSITION IS INSUFFICIENT TO ADVANCE GTX PLATFORM PROGRAM TO VALUE-ENHANCING MILESTONES WITHOUT SIGNIFICANT CAPITAL CONTRIBUTIONS

FURTHER DEVELOPMENT OF GTX PLATFORM IS CONSIDERED OPTIMAL IN COLLABORATION WITH AN EXTERNAL PARTNER OR IN A PRIVATE SETTING

 Source text for Workspace: nMFN64Mdmk
 Further company coverage: GUARD.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))